- Home
- THRD vs AFRI Comparison
THRD vs AFRI Comparison
Compare THRD & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- AFRI
- Stock Information
- Founded
- THRD 2019
- AFRI 1943
- Country
- THRD United States
- AFRI Gibraltar
- Employees
- THRD N/A
- AFRI N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- AFRI Packaged Foods
- Sector
- THRD Health Care
- AFRI Consumer Staples
- Exchange
- THRD Nasdaq
- AFRI Nasdaq
- Market Cap
- THRD 335.2M
- AFRI 275.5M
- IPO Year
- THRD 2022
- AFRI N/A
- Fundamental
- Price
- THRD $6.00
- AFRI $9.80
- Analyst Decision
- THRD Strong Buy
- AFRI
- Analyst Count
- THRD 3
- AFRI 0
- Target Price
- THRD $20.33
- AFRI N/A
- AVG Volume (30 Days)
- THRD 248.2K
- AFRI 12.6K
- Earning Date
- THRD 11-07-2024
- AFRI 01-28-2025
- Dividend Yield
- THRD N/A
- AFRI N/A
- EPS Growth
- THRD N/A
- AFRI N/A
- EPS
- THRD N/A
- AFRI N/A
- Revenue
- THRD N/A
- AFRI $325,098,000.00
- Revenue This Year
- THRD N/A
- AFRI N/A
- Revenue Next Year
- THRD N/A
- AFRI N/A
- P/E Ratio
- THRD N/A
- AFRI N/A
- Revenue Growth
- THRD N/A
- AFRI 15.94
- 52 Week Low
- THRD $5.60
- AFRI $9.63
- 52 Week High
- THRD $16.94
- AFRI $12.00
- Technical
- Relative Strength Index (RSI)
- THRD 23.75
- AFRI 41.95
- Support Level
- THRD $5.60
- AFRI $9.68
- Resistance Level
- THRD $11.78
- AFRI $10.36
- Average True Range (ATR)
- THRD 0.89
- AFRI 0.18
- MACD
- THRD -0.43
- AFRI -0.02
- Stochastic Oscillator
- THRD 6.50
- AFRI 17.65
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.